Incidence and Significance of Pericardial Effusion in Patients With Pulmonary Arterial Hypertension

Canadian Journal of Cardiology

Volumn 29, Issue 6, 2013, Pages 678-682

  Shimony, Avi ^a   Fox, Benjamin D ^a   Langleben, David ^a   Rudski, Lawrence G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PROGNOSIS; QUEBEC; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84878128958     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.04.009     Document Type: Article

References (20)

1. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009, 53:1573-1619.
2. Galiè N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
3. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54.
4. Farber H.W., Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004, 351:1655-1665.
5. Badesch D.B., Abman S.H., Simonneau G., Rubin L.J., McLaughlin V.V. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007, 131:1917-1928.
6. Bogaard H.J., Abe K., Vonk Noordegraaf A., Voelkel N.F. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009, 135:794-804.
7. McLaughlin V.V., Presberg K.W., Doyle R.L., et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004, 126:78S-92S.
8. Swiston J.R., Johnson S.R., Granton J.T. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med 2010, 104:1588-1607.
9. Hinderliter A.L., Willis P.W., Long W., et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. Am J Cardiol 1999, 84:481-484.
10. Raymond R.J., Hinderliter A.L., Willis P.W., et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002, 39:1214-1219.
11. Nagaya N., Nishikimi T., Uematsu M., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000, 102:865-870.
12. Eysmann S.B., Palevsky H.I., Reichek N., Hackney K., Douglas P.S. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989, 80:353-360.
13. Benza R.L., Miller D.P., Gomberg-Maitland M., et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010, 122:164-172.
14. Maisch B., Seferoviæ P.M., Ristiæ A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; the Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004, 25:587-610.
15. Thenappan T., Shah S.J., Rich S., Tian L., Archer S.L., Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010, 35:1079-1087.
16. Bossone E., Bodini B.D., Mazza A., Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005, 127:1836-1843.
17. Habib G., Torbicki A. The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension. Eur Respir Rev 2010, 19:288-299.
18. Brierre G., Blot-Souletie N., Degano B., Têtu L., Bongard V., Carrié D. New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension. Eur J Echocardiogr 2010, 11:516-522.
19. Mann C.J. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 2003, 20:54-60.
20. Pankuweit S., Wädlich A., Meyer E., Portig I., Hufnagel G., Maisch B. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 2000, 25:748-754.